Skip to main content

Smith & Nephew Plc Value Stock - Dividend - Research Selection

Smith + Nephew Plc

ISIN: GB0009223206, WKN: 502816

Market price date: 01.06.2021
Market price: 21,70 USD




Smith + Nephew Plc Fundamental data and company key figures of the share

Annual reports in USD
Key figures 27-02-2021
Cash flow
Net operating cash flow 935.000.000
Capital Expenditures -443.000.000
Free cash flow 492.000.000
Balance sheet
Total Equity 5.279.000.000
Liabilities & Shareholders equity 11.012.000.000
Income statement
Net income 448.000.000
Eps (diluted) 0,512
Diluted shares outstanding 875.000.000
Net sales/revenue 4.560.000.000

Fundamental ratios calculated on: 01-06-2021

Ratios
Key figures 01-06-2021
Cash flow
P/C 20,31
   
P/FC 38,59
Balance sheet
ROI4,07
ROE47,94
Income statement
P/E42,38
Div. Yield1,75%
P/B3,60
P/S4,16


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
SymbolSNNUF
Market Capitalization18.987.499.520,00 USD
Country
IndicesFTSE 100
Sectors
Raw Data SourceIFRS in Millionen USD
Stock Split
Internetwww.smith-nephew.com


Description of the company

Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices. The Sports Medicine Joint Repair franchise offers surgeons a range of instruments, technologies and implants necessary to perform minimally invasive surgery of the joints, including the repair of soft tissue injuries and degenerative conditions of the knee, hip and shoulder. The AET franchise offers an array of minimally invasive surgery-enabling systems and devices. The Trauma & Extremities franchise supports healthcare professionals with solutions used by surgeons to stabilize severe fractures, correct bone deformities, treat arthritis and heal soft tissue complications.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov, www.smith-nephew.com